Dominated by Lab Corp and Quest, the clinical laboratory services market is growing as new competitors enter. An essential part of the health industry, it is estimated that approximately 80% of physician’s diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. Those seeking to enter this business or to know more about it will benefit from Clinical Laboratory Services (Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles), an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S., demographics; life expectancy, and company strategies. Information is presented as a U.S. market, with a section on key international markets. A market summary includes a total market analysis, analysis by laboratory type, and an analysis for routine and specialty testing.

Also included is a competitive analysis of leading clinical laboratory providers.

Several leading market participants are discussed in this report. Some of these include:

• Quest Diagnostics, Inc.
• Laboratory Corporation of America
• Genzyme Corporation
• DaVita
• Clarient, Inc.
• Spectra Laboratories
• Bio-Reference Laboratories

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information.

Market Data Provided Includes:

• Hospital, Physician and Independent Lab Statistics
• Major Tests Performed by Clinical Lab Companies
• Disease Incidence and Trends Driving Lab Business
• Market Forecast
• Market Breakdown by Type (Hospital, Physician, Independent)
• Market Share of Competitors

For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
Feb 1, 2010 - KLI2565239 - $3,500.00

Kalorama Select Diagnostic Market Research Report Package
Jan 15, 2010 - KLI2577676 - $19,999.00

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Nov 1, 2009 - KLI2403357 - $3,995.00

2009 Worldwide Diagnostics Market Research Bundle
Oct 1, 2009 - KLI2401913 - $5,995.00

Infectious Disease Diagnostic Markets
Aug 1, 2009 - KLI2391680 - $3,500.00

Who is Who in Clinical Diagnostics in India (Markets, Distributors, Companies, Country Overview)
Aug 1, 2009 - KLID2254015 - $3,995.00

What Is Working in IVD: Successful Commercialization of New Products and Technologies
Jul 1, 2009 - KLI2283426 - $2,500.00

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
May 1, 2009 - KLI2241990 - $800.00

Who is Who in Clinical Diagnostics in China (Manufacturers and Distributors Profiles, Market, Industry Overview )
May 1, 2009 - KLID2217449 - $3,995.00